Vadodara, India

Palash Pal

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Palash Pal in Pharmaceutical Chemistry

Introduction

Palash Pal is an accomplished inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work has led to the development of innovative processes that enhance the efficiency of drug preparation.

Latest Patents

Palash Pal holds a patent for "Processes for preparation of Sugammadex and intermediates thereof." This invention relates to a process for the preparation of 6-perdeoxy-6-per-chloro gamma-cyclodextrin, which is a key intermediate useful in the synthesis of Sugammadex sodium. The patent further details a process for the preparation and purification of Sugammadex sodium, showcasing his expertise in this area.

Career Highlights

Throughout his career, Palash Pal has demonstrated a strong commitment to advancing pharmaceutical research. His innovative approaches have not only contributed to the scientific community but have also paved the way for more effective medical treatments.

Collaborations

Palash has collaborated with notable professionals in his field, including Lakshmi Prasad Alaparthi and Sadasiva Rao Ginjupalli. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Palash Pal's contributions to pharmaceutical chemistry through his innovative processes highlight his role as a significant inventor in the industry. His work continues to influence the development of important medical compounds, underscoring the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…